跳至主要内容
临床试验/IRCT20200106046029N1
IRCT20200106046029N1已完成3 期

Clinical evaluation of organ preservation HTK solution in clinical liver transplantation: a pilot randomized phase three clinical trial study

Pharmed Cina Caspian Pouyesh Company0 个研究点目标入组 28 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Patient undergoing liver transplantation
  • Age above 18 years old
  • Informed consent to enter the study

排除标准

  • Those with organ donations from outside of the province
  • Pregnant patients or those who are lactating
  • Those with donations after cardiac death (DCD)
  • Those who are undergoing re-transplantations
  • Those with machine perfusion

研究者

发起方
Pharmed Cina Caspian Pouyesh Company

相似试验